Provided by Tiger Trade Technology Pte. Ltd.

Femasys Inc

1.65
-0.0850-4.90%
Post-market: 1.650.00000.00%19:36 EDT
Volume:58.52K
Turnover:100.09K
Market Cap:13.82M
PE:-0.37
High:1.77
Open:1.70
Low:1.60
Close:1.74
52wk High:22.20
52wk Low:1.46
Shares:8.38M
Float Shares:6.31M
Volume Ratio:0.51
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4145
EPS(LYR):-9.4201
ROE:-424.97%
ROA:-84.22%
PB:3.43
PE(LYR):-0.18

Loading ...

Femasys doubles enrolling sites in FemBloc FINALE Pivotal Trial

TIPRANKS
·
Oct 14

Femasys Doubles Enrolling Sites to 12 in FemBloc Finale Pivotal Trial for Permanent Birth Control

Reuters
·
Oct 14

Femasys to Exhibit at ASRM Scientific Congress & Expo

Reuters
·
Oct 08

Femasys announces Minnesota Women’s Care to implement FemVue

TIPRANKS
·
Sep 15

Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care

GlobeNewswire
·
Sep 15

Femasys Partners with CapexMD to Offer Financing for FemaSeed Fertility Portfolio

Reuters
·
Sep 09

Femasys registers to sell 28.12M shares of common stock for holders

TIPRANKS
·
Sep 04

Femasys - Files for Resale of up to 28,124,997 Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Sep 04

Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations

GlobeNewswire
·
Aug 26

Femasys announces FDA approval of FemBloc modular premarket approval application

TIPRANKS
·
Aug 19

Femasys Says FDA OKs Modular PMA Pathway for FemBloc Birth Control Device

Reuters
·
Aug 19

Femasys - FDA Approves Modular Pma Pathway for Fembloc in the United States

THOMSON REUTERS
·
Aug 19

Femasys - Fembloc Approved for Marketing in Europe and Select International Markets

THOMSON REUTERS
·
Aug 19

Femasys is Maintained at Buy by Lake Street

Dow Jones
·
Aug 19

Femasys price target lowered to $10 from $30 at Lake Street

TIPRANKS
·
Aug 18

Femasys price target lowered to $10 from $30 at Maxim

TIPRANKS
·
Aug 16

Femasys Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Femasys Q2 EPS $(1.08) Beats $(1.33) Estimate, Sales $756.716K Beat $730.667K Estimate

Benzinga Earnings
·
Aug 15

Femasys Q2 Net Loss Narrows 2.55% to $4.47 Million; Net Sales Drop 18.9% to $331,827

Reuters
·
Aug 15

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

THOMSON REUTERS
·
Aug 15